マイナーカンナビノイド市場：製品別、用途別-2025-2030年の世界予測

マイナーカンナビノイド市場は、2023年に176億3,000万米ドルと評価され、2024年には187億9,000万米ドルに達すると予測され、CAGR 7.95％で成長し、2030年には301億3,000万米ドルに達すると予測されています。

急成長しているマイナーカンナビノイドの分野では、CBG、CBN、CBC、THCVなど、大麻に含まれる非精神活性化合物やあまり目立たない化合物が市場範囲を定義しています。これらのカンナビノイドは、その潜在的な治療効果により注目を集めており、医薬品、栄養補助食品、ウェルネス製品における必要性が高まっています。用途は、睡眠増強、食欲調節、疼痛緩和から潜在的な抗炎症作用や神経保護作用にまで及び、最終用途は医薬品製剤、嗜好品、化粧品、ペット用品に及ぶ。市場成長は、自然健康療法に対する消費者の意識の高まり、有利な規制の変化、大麻栽培・抽出技術の進歩に大きく影響されています。ターゲットとなるカンナビノイド製品の開発、臨床研究を目的とした提携、新興国市場と既存合法市場の両方における製品ラインの拡大など、市場開拓の機会は豊富にあります。しかし市場は、規制の曖昧さ、高い抽出コスト、長期的効果に関する限られた臨床データといった課題に直面しており、これらは迅速な商業化を妨げる可能性があります。新たなビジネスチャンスを生かすために、企業はエンタテインメント効果に焦点を当てた調査に投資すべきです。消費者の行動や嗜好をターゲットにしたデータ主導の戦略は、製品イノベーションの指針となり得る。さらに、サプライチェーンの透明性と持続可能性のためにブロックチェーンを統合することで、競争上の優位性がもたらされる可能性があります。マイナーカンナビノイド市場の性質はダイナミックであり、科学的共同研究やホリスティックな健康観に向けた法規制の進化がイノベーションの可能性を高めています。持続的な成長には、有利な規制の枠組みや製品の品質と安全性の標準化を引き続き提唱していくことが重要です。技術革新の中心は、抽出方法の最適化、正確な剤形による効能の最大化、特定の健康上の結果に合わせたマルチ・カンナビノイド・ブレンドの開発です。市場の情勢は、課題はあるにせよ、進化する消費者ニーズと技術の進歩に対応したビジネスの成長を約束しています。

市場力学：急速に進化するマイナーカンナビノイド市場の主要市場インサイトを公開

マイナーカンナビノイド市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • マイナーカンナビノイドの医療効果
  • カンナビノイドの合法化の進展
  • 新しいマイナーカンナビノイド飲食品のイントロダクション
• 市場抑制要因
  • マイナーカンナビノイドの高コスト
• 市場機会
  • マイナーカンナビノイドの継続的研究開発
  • より良い製品化のための資金調達と投資
• 市場の課題
  • マイナーカンナビノイドに関する厳しい規制

ポーターのファイブフォース：マイナーカンナビノイド市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、マイナーカンナビノイド市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：マイナーカンナビノイド市場における外部からの影響の把握

外部マクロ環境要因は、マイナーカンナビノイド市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析マイナーカンナビノイド市場における競合情勢の把握

マイナーカンナビノイド市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスマイナーカンナビノイド市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、マイナーカンナビノイド市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨マイナーカンナビノイド市場における成功への道筋を描く

マイナーカンナビノイド市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • マイナーカンナビノイドの医療上の利点
    • カンナビノイドの合法化が進む
    • 新しいマイナーカンナビノイド飲食品製品のイントロダクション
  • 抑制要因
    • マイナーカンナビノイドのコストが高い
  • 機会
    • マイナーカンナビノイドの継続的な研究開発
    • より良い製品商業化のための資金と投資
  • 課題
    • マイナーカンナビノイドに関する厳格な規制
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 マイナーカンナビノイド市場：製品別

• カンナビクロメン
• カンナビゲロール
• カンナビゲロール酸
• カンナビノール
• テトラヒドロカンナビバリン

第7章 マイナーカンナビノイド市場：用途別

• がん
• 炎症
• 神経疾患
• 疼痛管理

第8章 南北アメリカのマイナーカンナビノイド市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のマイナーカンナビノイド市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのマイナーカンナビノイド市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Fresh Bros Hemp Company
• GenCanna
• Global Cannabinoids
• Laurelcrest
• Mile High labs International
• Pacific Roots, LLC
• Rhizo Sciences
• Sanobiotec
• Zero Point Extraction, LLC

LIST OF FIGURES

• FIGURE 1. MINOR CANNABINOIDS MARKET RESEARCH PROCESS
• FIGURE 2. MINOR CANNABINOIDS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MINOR CANNABINOIDS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MINOR CANNABINOIDS MARKET DYNAMICS
• TABLE 7. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABICHROMENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROLIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABINOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY TETRAHYDROCANNABIVARIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. CANADA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 26. CANADA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CHINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 38. CHINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 40. INDIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ITALY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 75. ITALY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. POLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 83. POLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. QATAR MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 85. QATAR MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023

The Minor Cannabinoids Market was valued at USD 17.63 billion in 2023, expected to reach USD 18.79 billion in 2024, and is projected to grow at a CAGR of 7.95%, to USD 30.13 billion by 2030.

In the burgeoning field of minor cannabinoids, the market scope is defined by non-psychoactive and less prominent compounds found in cannabis, such as CBG, CBN, CBC, and THCV. These cannabinoids are gaining attention due to their potential therapeutic benefits, increasing their necessity in pharmaceuticals, nutraceuticals, and wellness products. Applications extend from sleep enhancement, appetite regulation, and pain relief to potential anti-inflammatory and neuroprotective effects, with end-use spanning medicinal formulations, edibles, cosmetics, and pet products. Market growth is significantly influenced by increasing consumer awareness of natural health remedies, favorable regulatory shifts, and advancements in cannabis cultivation and extraction technologies. Opportunities abound in the development of targeted cannabinoid products, partnerships aimed at clinical research, and expanding product lines in both emerging and established legal markets. However, the market faces challenges such as regulatory ambiguity, high extraction costs, and limited clinical data on long-term effects, which could hamper rapid commercialization. To capitalize on emerging opportunities, companies should invest in research focused on the entourage effect, which examines how minor cannabinoids interact with major ones for enhanced benefits. Data-driven strategies targeting consumer behavior and preferences could guide product innovation. Moreover, integrating blockchain for supply chain transparency and sustainability could offer competitive advantages. The nature of the minor cannabinoids market is dynamic, with high innovation potential driven by scientific collaborations and evolving legislations geared towards holistic health perspectives. Continued advocacy for favorable regulatory frameworks and the standardization of product quality and safety will be crucial for sustained growth. Innovation should center around optimizing extraction methods, maximizing efficacy through precise dosage forms, and developing multi-cannabinoid blends tailored to specific health outcomes. The market landscape promises growth for businesses attuned to evolving consumer needs and technological advancements, despite the presence of challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minor Cannabinoids Market

The Minor Cannabinoids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Medical benefits of minor cannabinoids
  • Increasing legalization of cannabinoids
  • Introduction of new minor-cannabinoid food & beverage products
• Market Restraints
  • High cost of minor cannabinoids
• Market Opportunities
  • Ongoing R&D of minor cannabinoids
  • Funding and investments for better product commercialization
• Market Challenges
  • Strict regulations regarding minor cannabinoids

Porter's Five Forces: A Strategic Tool for Navigating the Minor Cannabinoids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minor Cannabinoids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minor Cannabinoids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minor Cannabinoids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minor Cannabinoids Market

A detailed market share analysis in the Minor Cannabinoids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minor Cannabinoids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minor Cannabinoids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minor Cannabinoids Market

A strategic analysis of the Minor Cannabinoids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minor Cannabinoids Market, highlighting leading vendors and their innovative profiles. These include Fresh Bros Hemp Company, GenCanna, Global Cannabinoids, Laurelcrest, Mile High labs International, Pacific Roots, LLC, Rhizo Sciences, Sanobiotec, and Zero Point Extraction, LLC.

Market Segmentation & Coverage

This research report categorizes the Minor Cannabinoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Products, market is studied across Cannabichromene, Cannabigerol, Cannabigerolic Acid, Cannabinol, and Tetrahydrocannabivarin.
• Based on Application, market is studied across Cancer, Inflammation, Neurological Disorders, and Pain Management.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Medical benefits of minor cannabinoids
    • 5.1.1.2. Increasing legalization of cannabinoids
    • 5.1.1.3. Introduction of new minor-cannabinoid food & beverage products
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of minor cannabinoids
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D of minor cannabinoids
    • 5.1.3.2. Funding and investments for better product commercialization
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations regarding minor cannabinoids
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Minor Cannabinoids Market, by Products

• 6.1. Introduction
• 6.2. Cannabichromene
• 6.3. Cannabigerol
• 6.4. Cannabigerolic Acid
• 6.5. Cannabinol
• 6.6. Tetrahydrocannabivarin

7. Minor Cannabinoids Market, by Application

• 7.1. Introduction
• 7.2. Cancer
• 7.3. Inflammation
• 7.4. Neurological Disorders
• 7.5. Pain Management

8. Americas Minor Cannabinoids Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Minor Cannabinoids Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Minor Cannabinoids Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Fresh Bros Hemp Company
• 2. GenCanna
• 3. Global Cannabinoids
• 4. Laurelcrest
• 5. Mile High labs International
• 6. Pacific Roots, LLC
• 7. Rhizo Sciences
• 8. Sanobiotec
• 9. Zero Point Extraction, LLC